Practically scheduling hormone therapy for prostate cancer using a mathematical model
A Nakanishi, Y Hirata - Journal of Theoretical Biology, 2019 - Elsevier
Hormone therapy is one of the popular therapeutic methods for prostate cancer. Intermittent
androgen suppression (IAS) is the method which stops and resumes hormone therapy …
androgen suppression (IAS) is the method which stops and resumes hormone therapy …
Revisiting intermittent therapy in metastatic prostate cancer: can less be more in the “new world order”?
J Shevach, MR Sydes, M Hussain - European Urology Focus, 2019 - Elsevier
Context Androgen deprivation therapy (ADT) is the standard of care for men with metastatic
hormone-sensitive prostate cancer (HSPC) and a potential treatment option in those with …
hormone-sensitive prostate cancer (HSPC) and a potential treatment option in those with …
Molecular mechanisms driving prostate cancer neuroendocrine differentiation
JE Sutton - 2019 - napier-repository.worktribe.com
Annually, 11,500 men in the UK die of prostate cancer (PCa). PCa tumours are initially
dependent upon androgen receptor (AR) signalling and androgen deprivation therapy …
dependent upon androgen receptor (AR) signalling and androgen deprivation therapy …